Latest Breaking News On - Evaluating early melanoma development - Page 1 : vimarsana.com

/PRNewswire/ In a first-in-human study, researchers at Orlucent, Inc. have demonstrated the viability of a novel handheld point-of-care molecular Skin.

United statesSancy leachmanJeff christensenCatherine shachafMelanoma researchMelanoma research programOregon health science university knight cancer instituteOrlucent incA tool for evaluating early melanoma developmentSkin fluorescence imagingPigment cellBreakthrough deviceSkin fluorescence imaging systemOregon healthScience university knight cancer instituteEvaluating early melanoma development